Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung cancer, 2011 - Elsevier
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung cancer (Amsterdam, Netherlands), 2011 - pubmed.ncbi.nlm.nih.gov
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung Cancer, 2011 - pure.johnshopkins.edu
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.
A Chang - Lung Cancer (Amsterdam, Netherlands), 2010 - europepmc.org
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …
[引用][C] Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A CHANG - Lung cancer, 2011 - pascal-francis.inist.fr
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung Cancer, 2011 - lungcancerjournal.info
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …
[引用][C] Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung Cancer, 2011 - cir.nii.ac.jp
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung Cancer, 2011 - infona.pl
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung Cancer, 2011 - infona.pl
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …